Latest News

Critical access hospitals in rural areas continue to be threatened by unsustainable operating costs, but a recent blog post on Health Affairs proposed an innovative solution to ensure access to care persists in these areas: freestanding emergency centers.
The announcements come as Medicare is set to start reimbursing the Diabetes Prevention Program on January 1, 2018.
Including anti-cholesterol agents during adjuvant endocrine treatment can prevent breast cancer recurrence in hormone receptor–positive early-stage breast cancer.
Christine Bernsten Discusses Health Share of Oregon's Involvement with Project ECHO
Investing in Project ECHO allowed Health Share to offer continuing education for providers, and many of them now say they enjoy participating in the program, said Christine Bernsten, senior manager of delivery systems transformation for Health Share of Oregon.
Two surveys, one each for patients and providers, reveal gaps between patient confidence to manage disease or pain and what they'd like to see from their physicians.
Adverse events from cancer clinical trials are currently reported by trial investigators, but a recent feasibility study found that patients can successfully and accurately report their own symptoms if given the opportunity.
New research indicates that Medicare patients were more likely to continue using opioid painkillers a year after a visit to the emergency department if they had been treated there by a physician that frequently prescribes opioids.
This small study found sustained weight loss of 10% of body weight in patients who were overweight but not obese, along with improvements in glycemic control and quality of life that exceeded patients taking medication only.
The presentation at HIMSS 2017 comes after a record-breaking year in healthcare data breaches.
Dr Roy Beveridge on Physician Reaction to Value-Based Payment Models
The introduction of value-based payment models means that the goals of providing optimal patient care have become aligned for the clinician and the insurer, leading to more cooperation and support, said Roy Beveridge, MD, chief medical officer of Humana. This represents a shift from the more adversarial relationship between physicians and payers that existed under fee-for-service models.
Here you can access pages highlighted in our Instagram feed.
The trial successfully improved progression-free survival and also tested a BRCA diagnostic test in patients with ovarian cancer.

From the Journals

Pam Mangat, MS, associate director for the TAPUR study in the research and analysis division of the American Society of Clinical Oncology, offered an update on the study at the 5th annual Patient-Centered Oncology Care® meeting.
David L. Porter, MD, kicked off the 5th annual Patient-Centered Oncology Care® (PCOC®) meeting in Baltimore on November 17, 2016, with an update on chimeric antigen receptor T-cell therapy.
At the 5th annual Patient-Centered Oncology Care® meeting, hosted by The American Journal of Managed Care®, experts discussed the contradiction presented by immuno-oncology agents in the world of precision medicine.
At the 5th annual Patient-Centered Oncology Care® meeting, Nell Wood Buhlman of Press Ganey explained that oncology providers must focus on patient needs and minimize suffering in order to truly provide value in cancer care.
Bruce A. Feinberg, DO, moderated a panel at the 5th annual Patient-Centered Oncology Care® meeting that brought stakeholders together to share their cancer care predictions for the upcoming year.
Roy Beveridge, MD, senior vice president and chief medical officer at Humana, provided an overview of the transition to value-based care at the 5th annual Patient-Centered Oncology Care® meeting.
The shift to value-based care, concurrent with innovations in immune-based care, will create challenges in oncology. What should be the physician and manufacturer responsibility during these changing times?
Patients, caregivers, and providers need education on immunotherapy treatment, support in patient-provider communications as well as support in mitigating the financial impact of immunotherapy treatment.
An oncologist provides insight on his experience with using CAR-T therapy in the clinic and his prediction for the future of this revolutionary treatment.
Compendia
COPD Compendium
Diabetes Compendium
GI Compendium
MACRA Compendium
Oncology Compendium
Rare Disease Compendium
Reimbursement Compendium
Know Your News
HF Compendium
Formulary
Upcoming Partner Events
March 1-2, 2017
Scottsdale, AZ
March 9-10, 2017
Washington, DC
March 15-16, 2017
Philadelphia, PA
March 16-17, 2017
Baltimore, MD
April 19-20, 2017
San Francisco, CA
August 16-17, 2017
Philadelphia, PA
October 24-25, 2017
San Francisco, CA
Managed Care Cast
Managed Care Cast

Most Popular

AJMC Strategic Alliance

$vacMongoViewPlus$